The news is by your side.

Generic drugmaking

Mylan to buy Abbott generics in a $5.3 billion deal

WASHINGTON: Generic drugmaker Mylan Inc said on Monday it would buy Abbott Laboratories' branded specialty and generics business in developed markets outside the United States in a $5.3 billion deal that will bolster its product line and also cut its tax bill.